Loading compound...

Small molecule cancer research compound

CARBOXYAMIDOTRIAZOLE (also known as Carboxyami) is a small molecule currently being studied in clinical trials. It is being researched for its potential to treat various types of cancer, including lung, kidney, and ovarian cancers.

Used for
non-small cell lung carcinomaperitoneum cancerfallopian tube cancerkidney cancerovarian cancerrenal cell carcinomaglioblastoma
Conditions
non-small cell lung carcinomaperitoneum cancerfallopian tube cancerkidney cancerovarian cancerrenal cell carcinomaglioblastoma
Class
Small moleculeAntineoplasticSmall molecule cancer research compoundRespiratory systemGenitourinary systemReproductive systemNervous system

How to take

This drug is currently in the research phase (up to Phase 3) and is not yet an approved treatment for any condition.

Talk to your doctor

Questions to ask

  • ·Is CARBOXYAMIDOTRIAZOLE part of a clinical trial I can join?
  • ·What are the potential risks of CARBOXYAMIDOTRIAZOLE?
  • ·How does CARBOXYAMIDOTRIAZOLE work for my specific type of cancer?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.